Latest Optical coherence tomography Stories
Scientists in Poland are describing how a medical imaging technique has taken on a second life in revealing forgery of an artist's signature and changes in inscriptions on paintings that are hundreds of years old.
NPL 'phantoms' will validate new technique which monitors changes in cell structures.
SAN DIEGO, Jan.
BILLERICA, Mass., Dec. 4 /PRNewswire-FirstCall/ -- Axsun Technologies, Inc., a wholly-owned subsidiary of Volcano Corporation (Nasdaq: VOLC), today announced the initial development and successful testing of a novel integrated light source architecture for OCT imaging.
WESTFORD, Mass., Sept.
SAN JOSE, Calif., June 2 /PRNewswire-FirstCall/ -- Oclaro, Inc. (Nasdaq: OCLR), has announced that its New Focus(TM) 2117 photoreceivers are underpinning an award winning breakthrough cancer detection system developed by scientists from Japan's Kitasato University.
Volcano's Axsun Laser - At the Heart of OCT SAN DIEGO and BARCELONA, Spain, May 19 /PRNewswire-FirstCall/ -- Volcano Corporation (Nasdaq: VOLC), a leader in the development, manufacturing and sales of products for the diagnosis of coronary and peripheral artery disease, today highlights its technology leadership position in the emerging field of Optical Coherence Tomography (OCT) at the EuroPCR conference in Barcelona, Spain. Volcano's wholly owned subsidiary, Axsun, has developed what we...
Launch of C7XR(TM) FD-OCT Imaging System and Companion C7 Dragonfly(TM) Imaging Catheter Strengthen LightLab's Market Leadership WESTFORD, Mass., May 14 /PRNewswire/ -- LightLab Imaging Inc., the pioneer and leader in the development of Optical Coherence Tomography (OCT) for vascular and other applications, today announced the launch of its next-generation system, the C7XR FD-OCT Imaging System with the C7 Dragonfly Imaging Catheter, at EuroPCR 2009, Barcelona, Spain, solidifying the...
SAN DIEGO, May 12 /PRNewswire-FirstCall/ -- Volcano Corporation (Nasdaq: VOLC), a leader in the development, manufacturing and sales of products for the diagnosis and treatment of coronary and peripheral artery disease, said today that it will be participating in the Eighth Annual JMP Securities Research Conference on Monday, May 18. The presentation by John Dahldorf, chief financial officer, will begin at 3:00 p.m., Pacific Daylight Time (6:00 p.m., Eastern Daylight Time). The presentation...
SAN DIEGO, Jan.
- Monstrous in size or character; huge; prodigious; monstrously perverse, savage, cruel, etc.